Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Status:
RECRUITING
Trial end date:
2028-08-30
Target enrollment:
Participant gender:
Summary
This study is a multicenter, randomized, controlled phase III clinical trial aimed at comparing the efficacy of two induction chemotherapy regimens-VA (Venetoclax + Azacitidine) and D/IA (Daunorubicin/Idarubicin + Cytarabine)-in elderly patients (aged 60-75) with acute myeloid leukemia (AML) who are fit for intensive chemotherapy.
Phase:
PHASE3
Details
Lead Sponsor:
Institute of Hematology & Blood Diseases Hospital, China